3rd Annual Pharmacovigilance & Risk Management Summit

Our 3rd Summit will gather PV professionals to discuss strategies for prioritizing compliance and quality through new technology and collaboration.

The extensive group of experts will discuss the advances and new trends in EU legislation, audit and inspection preparation, signal detection practices, implementation of risk management plans, the impact of IT and social media on PV, and harmonization of different regulatory bodies.

Key Practical Learning Points of the Summit:

  • Good signal detection practices
  • New approaches to signal management
  • The benefits of Risk Management and monitoring the effectiveness of risk minimization
  • European safety and Risk Management of biosimilars
  • Planning and preparing for Pharmacovigilance inspections according to the various requirements
  • Implementation of a Pharmacovigilance System Master File and inspection preparation
  • Latest innovations and trends in drug safety

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Pharmacovigilance
  • Drug Safety
  • Product Safety
  • Risk Management
  • RMPs
  • Qualified Persons Responsible for Pharmacovigilance QPPV
  • GPvP
  • ICH-GCP
  • PV Inspection and Audit
  • Signal Management
  • Signal Detection
  • PSUR/PBRER
  • PV Agreements
  • PASS/PAES
  • PSMF
  • Adverse Drug Reactions (ADR)

From Industries Including:

  • Pharmaceuticals
  • Health Care
  • Hospital
  • Medical Practice
  • Biotechnology
  • Biologics
  • Clinical Research Organizations
  • Academic Research Centers
  • Regulatory Agencies
Speakers

Previous Year Attendees

  • Bayer Pharma AG, Germany
    Vice President, Head of GMA WH&EP

  • Bayer Pharma AG, Germany
    Senior GMA Physician

  • LLC Teva Ukraine, Ukraine
    Person responsible for Pharmacovigilance

  • Bayer Pharma AG, Germany
    TA Head Risk Management GPVCC

  • Bayer Pharma AG, Germany
    Global Safety Leader

  • Bayer Pharma AG, Germany
    Global Clinical Leader

  • F. Hoffmann-La Roche, Switzerland
    Business Solution Manager

  • Heaton k.s., Czech Republic
    CEO

  • Roche China Holding Limited, China
    Safety Science

  • Elsevier Information Systems GmbH, Germany
    Solution Marketing Manager

  • Elsevier Information Systems GmbH, Germany
    Global Vendor Relations Manager, Life Sciences

  • Debiopharm International, Switzerland
    Senior Pharmacovigilance Officer

  • Biogen International HQ, Germany
    Medical Operations/PV

  • Biogen GmbH, Germany
    Head of Drug Safety

  • Stallergenes SAS, France
    Head of Drug Safety Evaluation EU QPPV

  • Quintiles, Germany
    Senior Director Business Development RWLPR

  • Elsevier B.V., The Netherlands
    V.P. Solution Sales Life Sciences

  • GlaxoSmithKline (GSK), Belgium
    VCSP Global Process Owner

  • Institut de Recherches Internationales Servier, France
    Biostatistician

  • Elsevier B.V., The Netherlands
    Regional Manager Pharmaceutical Biotech Mature Europe